Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients

NCT06073730 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Elderly AML Patients
Unfit, New-diagnosis AML
Acute Myeloid Leukemia
Venetoclax
Decitabine

Interventions

PROCEDURE: Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
PROCEDURE: Active Comparator: Standard dose of Venetoclax + Azacitidine

Sponsor

The Second Affiliated Hospital of Kunming Medical University